截至6月3日收盘，市场冲高回落，沪深两市成交额3.13万亿元。医药ETF（512120）下跌1.46%，港股通生物科技ETF（159102）下跌3.11%。相关个股方面，金斯瑞生物科技上涨10.54%、信达生物下跌2.54%、百济神州下跌2.13%、药明生物下跌7.00%。 消息面上，翰森制药6月4日在港交所公告，于6月3日，公司创新药奥莱泊肽注射液上市许可申请（NDA）获中国国家药品监督管理局...
Source Link截至6月3日收盘，市场冲高回落，沪深两市成交额3.13万亿元。医药ETF（512120）下跌1.46%，港股通生物科技ETF（159102）下跌3.11%。相关个股方面，金斯瑞生物科技上涨10.54%、信达生物下跌2.54%、百济神州下跌2.13%、药明生物下跌7.00%。 消息面上，翰森制药6月4日在港交所公告，于6月3日，公司创新药奥莱泊肽注射液上市许可申请（NDA）获中国国家药品监督管理局...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.